546TiPTepotinib in non-small cell lung cancer (NSCLC) with MET-exon 14 skipping mutations (METex14+) and MET amplification (METamp); A phase II trial in progress. (25th November 2018) - Paik, P; Sakai, H; Bruns, R; Scheele, J; Straub, J; Felip, E